Skip to Main Content

Why the Janssen/Johnson & Johnson Pause Should Make You Feel Safer


Thomas G. McGinn, MD, MPH System Executive Vice President, CommonSpirit Health

On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) jointly announced a recommendation to pause administration of the Janssen/Johnson & Johnson (J&J) vaccine as it undergoes further investigation for rare blood clotting events.

Publish date: 

Tuesday, May 25, 2021

News

A Unique Collaboration to Address Vaccine Hesitancy

JAN 19, 2023

The COVID-19 pandemic required collaboration to address vaccine hesitancy in populations of color. CommonSpirit collaborated with a philanthropic organization and a technology company to increase access to COVID-19 vaccines.

Read More Additional information about A Unique Collaboration to Address Vaccine Hesitancy

Is it COVID, the flu, or RSV? 5 Questions Answered

JAN 17, 2023

Dr. Gary Greensweig, Chief Physician Executive for the Physician Enterprise at CommonSpirit Health, addresses some common questions about COVID, flu and RSV.

Read More Additional information about Is it COVID, the flu, or RSV? 5 Questions Answered

Dr. McGinn 5-Minute Check-In

JAN 17, 2023

In this edition of his 5-minute check-in, Dr. Thomas McGinn, EVP of Physician Enterprise, discusses the latest numbers in the "Quadrademic" (COVID-19, RSV, influenza and common cold), including the rise of the newest COVID variant.

Read More Additional information about Dr. McGinn 5-Minute Check-In